Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $5000.00 | Pages : 401 | Published : September 2021 | SKU CODE : o&s320 | Format :

Request Sample

Central Nervous System Drugs Market Definition

The central nervous system (CNS) drugs market consists of sales of central nervous system drugs and related services by entities (organizations, sole traders and partnerships) that manufacture central nervous system drugs that are used in the treatment of diseases affecting the brain or spinal cord. The CNS drugs include anesthetics, anticonvulsants, antiemetics, antiparkinsonian agents, CNS stimulants, analgesics, and sedatives. Neurological diseases such as Epilepsy, Parkinson and psychological indications such as depression, and dementia are generally treated through these CNS drugs.  

Nervous system disorders are defined as disorders that affect the brain as well as the nerves found throughout the human body and the spinal cord. Structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves can result in a range of symptoms. Some of the common clinical indications of such disorders include paralysis, muscle weakness, poor coordination, loss of sensation, seizures, confusion, pain and altered levels of consciousness. These also include mental health conditions such as depression and post-traumatic stress disorder (PTSD). The market for CNS disorder drugs comprises of drugs that work in different ways depending on the type of disease by suppressing or boosting the brain activities.

Central Nervous System Drugs Market Size

The global central nervous system drugs market reached a value of nearly $125,277.9 million in 2020, having increased at a compound annual growth rate (CAGR) of 4.6% since 2015.  The market is expected to grow from $125,277.9 million in 2020 to $163,045.4 million in 2025 at a rate of 5.4%. The growth is mainly due to the increasing prevalence of psychological disorders which is expected to drive the demand for central nervous system drugs. The central nervous system (CNS) drugs market is expected to grow from $163,045.4 million in 2025 to $210,912.9 million in 2030 at a CAGR of 5.3%.  

Growth in the historic period resulted from increasing number of surgeries, strong growth in emerging markets, and increase in pharmaceutical R&D, geriatric population and increased healthcare expenditure. Factors that negatively affected growth in the historic period were patent expiry on drugs, pricing pressure from regulators, regulatory hurdles, low healthcare access, increased preference for biological treatments, and high cost of drug approval.

Going forward, growing government initiatives for mental health awareness, rise in healthcare expenditure, increasing geriatric population and strong pipeline of drugs will drive the growth. Factors that could hinder the growth of the central nervous system drugs market in the future include coronavirus pandemic, high costs of drugs, rising popularity of alternative therapies and natural remedies and low per capita healthcare expenditure.

Central Nervous System Drugs Market Drivers

The key drivers of the central nervous system drugs market include:

Growing Government Initiatives For Mental Health Awareness

The market in the forecast period is expected to be supported by growing government for mental health awareness. While developing countries such as countries in North America and Western Europe already had a reasonable understanding and access to mental healthcare, and thus anti-depressants, this demand has increased multifold owing to the pandemic. The pandemic has had a significant toll on the mental health owing to the psychological toll of isolation, loneliness, unemployment, financial stressors, and the loss of loved ones. Governments across the globe are therefore investing in mental health awareness, which is expected to allow people to get adequate help, and support the growth of the market. For instance, the UK’s government launched a Mental Health Recovery Action Plan on March 2021. The government is expected to spend £500 million to support people suffering from severe mental illnesses, including depression and PTSD, and those impacted by the pandemic. Countries such as Australia also invested about $2.3 billion for National Mental Health and Suicide Prevention Plan during the pandemic. This includes funds for increase in treatment for mental health diseases and adding up to 57 mental health treatment sites for adults, thus supporting the growth of the market.

Central Nervous System Drugs Market Restraints

The key restraints on the central nervous system drugs market include:

High Costs of Drugs

High costs associated with drugs is a major issue faced by citizens of many countries. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, the lack of cost-effective drugs has influenced the health conditions of the population and has led to a low average life expectancy. As a result, in countries such as Chad, Macedonia, Serbia, pharmaceutical companies are faced with the pressure of reducing the price of drugs. The high costs associated with drugs are putting pressure on the revenues of CNS drug manufacturers.

Central Nervous System Drugs Market Trends

Major trends influencing the central nervous system drugs market include:

Wearables To Improve R&D

Pharmaceutical companies are partnering with technology companies and incorporating wearables in clinical studies and for research and development of CNS disease treatments. These wearable devices make use of sensors to detect early symptoms of Parkinson’s disease such as tremors, slowness and stiffness in patients. Researchers use this data to gain insights about the disease and potential drug reactions, and thus reducing the time for trials by 30% to 50%. For instance, in 2016, Michael J. Fox Foundation for Parkinson’s Research collaborated with specialty drug maker Cynapsus Therapeutics and Intel to integrate wearable technology in a Phase-III clinical trial of APL-130277, an experimental drug for Parkinson’s disease. Biogen, a leading CNS drug maker is using Fitbit, a smart wearable tracker, to better understand multiple sclerosis in patient studies, and the technology is expected to extend in Alzheimer’s disease research

Biomarkers In CNS Drug Development

Drug manufacturers are increasingly using biomarkers to improve CNS drug development process. A biomarker is a biological variable which has a statistically significant relationship with parameters of disease states or drug candidates. It can be used to diagnose or predict disease, monitor disease progression and predict treatment response. Examples of biomarkers include protein levels, axonal damage, pulse, blood pressure and complex laboratory tests of blood and other tissues. Biomarkers can increase the statistical power of clinical trials and predict drug accuracy better than conventional clinical endpoints. This enhances product development and results in more effective treatments. Major drug makers such as Pfizer, Biogen, Amgen, Novartis AG, Merck, Eli Lilly and Sanofi are involved in CNS biomarker drug development.

Opportunities And Recommendations In The Central Nervous System Drugs Market

Opportunities –The top opportunities in the central nervous system drugs market segmented by type will arise in the multiple sclerosis segment, which will gain $8,679.9 million of global annual sales by 2025.The top opportunities in the central nervous system drugs market segmented by distribution channel will arise in the hospital pharmacies segment, which will gain $24,932.2 million of global annual sales by 2025. The top opportunities in the central nervous system drugs market segmented by route of administration will arise in the oral segment, which will gain $19,555.4 million of global annual sales by 2025. The top opportunities in the central nervous system drugs market segmented by drug classification will arise in the branded segment, which will gain $22,581.3 million of global annual sales by 2025. The top opportunities in the central nervous system drugs market segmented by mode of purchase will arise in the prescription segment, which will gain $35,375.0 million of global annual sales by 2025.  The central nervous system drugs market size will gain the most in the USA at $13,589.8 million

Recommendations-To take advantage of the opportunities, The Business Research Company recommends the central nervous system drugs companies to focus on 3d printing technology, collaborations for CNS drug development, adopting biomarkers, expanding in emerging markets, provide competitively priced offerings in low-income countries, adopt premium pricing, participate in trade shows and events, targeting physicians and hospitals to spread awareness, increase visibility through business websites and listing websites and targeting hospitals and pharmacies to spread awareness.

Central Nervous System Drugs Market Segmentation

The central nervous system drugs market is segmented by type, by distribution channel, by distribution channel, by drug classification, by mode of purchase.
By Type-
The central nervous system drugs market is segmented by type into
    • a) Multiple Sclerosis (MS)
    • b) Anti-Psychotic
    • c) Analgesics
    • d) Anti-Parkinson Drugs
    • e) Anesthetics
    • f) Anti-Epileptics
    • g) Anti-Depressants
    • h) Other CNS Drugs
The multiple sclerosis market was the largest segment of the central nervous system drugs market segmented by type, accounting for 27.4% of the total in 2020. Going forward, the other CNS drugs segment is expected to be the fastest growing segment in the central nervous system drugs market, at a CAGR of 7.7% during 2020-2025.
By Distribution Channel –
The central nervous system drugs market is segmented by distribution channel into
    • a) Hospitals Pharmacies
    • b) Retail Pharmacies/ Drug Stores
    • c) Others
The hospital pharmacies market was the largest segment of the central nervous system drugs market segmented by distribution channel, accounting for 62.6% of the total in 2020. Going forward, the others segment is expected to be the fastest growing segment in the central nervous system drugs market, at a CAGR of 13.1% during 2020-2025.
By Route Of Administration –
The central nervous system drugs market is segmented by route of administration into
    • a) Oral
    • b) Intravenous
    • c) Intranasal/ Inhalation
    • d) Others
The oral market was the largest segment of the central nervous system drugs market segmented by route of administration, accounting for 51.5% of the total in 2020. Going forward, the intranasal segment is expected to be the fastest growing segment in the central nervous system drugs market, at a CAGR of 6.7% during 2020-2025.
By Drug Classification –
The central nervous system drugs market is segmented by drug classification into
    • a) Branded Drugs
    • b) Generic Drugs
The branded drugs market was the largest segment of the central nervous system drugs market segmented by drug classification, accounting for 74.9% of the total in 2020. Going forward, the generic drugs segment is expected to be the fastest growing segment in the central nervous system drugs market, at a CAGR of 8.2% during 2020-2025.
By Mode Of Purchase –
The central nervous system drugs market is segmented by mode of purchase into
    • a) Over-The-Counter Drugs
    • b) Prescription-Based Drugs
The prescription market was the largest segment of the central nervous system drugs market segmented by mode of purchase, accounting for 84.1% of the total in 2020. Going forward, the prescription segment is expected to be the fastest growing segment in the central nervous system drugs market, at a CAGR of 6.0% during 2020-2025.
By Geography-
The central nervous system drugs market is segmented by geography into
    • o Asia Pacific
    • • China
    • • Australia
    • • Hong Kong
    • • India
    • • Indonesia
    • • Japan
    • • Malaysia
    • • New Zealand
    • • Philippines
    • • Singapore
    • • South Korea
    • • Thailand
    • • Vietnam
    o North America
    • • Canada
    • • Mexico
    • • USA
    o South America
    • • Argentina
    • • Brazil
    • • Chile
    • • Colombia
    • • Peru
    • • Venezuela
    o Western Europe
    • • Austria
    • • Belgium
    • • Denmark
    • • Finland
    • • France
    • • Germany
    • • Ireland
    • • Italy
    • • Netherlands
    • • Norway
    • • Portugal
    • • Spain
    • • Sweden
    • • Switzerland
    • • UK
    o Eastern Europe
    • • Poland
    • • Romania
    • • Czech Republic
    • • Russia
    o Middle East
    • • Saudi Arabia
    • • Israel
    • • Turkey
    • • UAE
    o Africa
    • • Egypt
    • • Nigeria
North America was the largest region in the global central nervous system drugs market, accounting for 47.8 % of the total in 2020. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the central nervous system drugs market will be the South America and Africa where growth will be at CAGRs of 8.6% and 7.4% respectively during 2020-2025. These will be followed by Middle East and Asia Pacific, where the markets are expected to grow at CAGRs of 6.9% and 6.5% respectively.

Central Nervous System Drugs Market Competitive Landscape

Major Competitors In The Central Nervous System Drugs Market Are:

  • Biogen Inc.
  • Johnson & Johnson
  • Hoffmann-La Roche Ltd
  • Novartis AG
  • UCB
  • Other Competitors In The Central Nervous System Drugs Market Include:

  • Sanofi
  • Pfizer Inc.
  • Merck KGaA
  • Sumitomo Dainippon Pharma
  • AbbVie
  • Recipharm AB
  • Neuraxpharm
  • Ranbaxy Laboratories
  • Merz Pharma GmbH & Co.
  • AstraZeneca
  • Roche Pharma
  • Sun Pharmaceutical limited
  • Apotex
  • Gilead Sciences
  • Bayer
  • GlaxoSmithKline
  • Amgen
  • Pasteur
  • Abbott Laboratories
  • Janssen Pharmaceutica
  • Teva Canada
  • Accord Healthcare Inc.
  • Acerus Pharmaceuticals Corporation
  • EMS Pharma
  • Hypermarcas
  • Eurofarma
  • Teuto Brasileiro
  • Biolab Farmaceutica
  • Cristalia
  • União Quimica
  • Boehringer Ingelheim
  • Eli Lilly and company
  • Adcock Ingram
    1. Table Of Contents

      1. Central Nervous System Drugs Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1. Segmentation By Geography

      6.2. Segmentation By Type

      6.3. Segmentation By Distribution Channel

      6.4. Segmentation By Route Of Administration

      6.5. Segmentation By Drug Classification

      6.6. Segmentation By Mode Of Purchase

      7. Central Nervous System Drugs Market Characteristics

      7.1. Market Definition

      7.2. Market Segmentation By Type

      7.2.1. Multiple Sclerosis (MS)

      7.2.2. Anti-Psychotic

      7.2.3. Analgesics

      7.2.4. Anti-Parkinson Drugs

      7.2.5. Anesthetics

      7.2.6. Anti-Epileptics

      7.2.7. Anti-Depressants

      7.2.8. Other CNS Drugs

      7.3. Market Segmentation By Distribution Channel

      7.3.1. Hospitals Pharmacies

      7.3.2. Retail Pharmacies/ Drug Stores

      7.3.3. Others

      7.4. Market Segmentation By Route Of Administration

      7.4.1. Oral

      7.4.2. Intravenous

      7.4.3. Intranasal/ Inhalation

      7.4.4. Others

      7.5. Market Segmentation By Drug Classification

      7.5.1. Branded Drugs

      7.5.2. Generic Drugs

      7.6. Market Segmentation By Mode Of Purchase

      7.6.1. Over-The-Counter Drugs

      7.6.2. Prescription-Based Drugs

      8. Central Nervous System Drugs Market, Supply Chain Analysis

      8.1. Supply Chain

      8.1.1. Raw Material Suppliers

      8.1.2. Contract Research Organization (CRO)

      8.1.3. Central Nervous System Drugs Manufacturer

      8.1.4. Contract Manufacturing Organization (CMO)

      8.2. Distribution

      8.2.1. Wholesalers/Distributors

      8.2.2. Retailers (Pharmacies) And Hospitals

      8.2.3. Neurologists

      8.3. End-Users

      9. Central Nervous System Drugs Market, Product Analysis – Product Examples

      10. Central Nervous System Drugs Market Customer Information

      10.1. Usage of Central Nervous System Medicines In Old Age Homes

      10.2. Study On Effectiveness Of Anti-Depressants

      10.3. Lower Approval Rates For Central Nervous System Drugs

      11. Central Nervous System Drugs Market Trends And Strategies

      11.1. Wearables To Improve R&D

      11.2. Biomarkers In CNS Drug Development

      11.3. Modification Of Existing Epilepsy Drugs

      11.4. Collaborations For CNS Drug Development

      11.5. Drug Pipeline

      11.6. 3D Printing Technology

      12. Leading Central Nervous System Drugs

      13. Pipeline Drugs

      14. Impact Of COVID-19 On The Central Nervous System Drugs Market

      14.1. Clinical Trial Delays

      14.2. Supply Chain Issues

      14.3. Increasing Demand For Anti-Depressants Due To COVID-19

      14.4. Future Outlook

      15. Global Central Nervous System Drugs Market Size And Growth

      15.1. Market Size

      15.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.2.1. Drivers Of The Market 2015 – 2020

      15.2.2. Restraints On The Market 2015 – 2020

      15.3. Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      15.3.1. Drivers Of The Market 2020 – 2025

      15.3.2. Restraints On The Market 2020 – 2025

      16. Central Nervous System Drugs Market, Regional Analysis

      16.1. Global Central Nervous System Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.2. Global Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Region

      16.3. Global Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Region

      17. Global Central Nervous System Drugs Market Segmentation

      17.1. Global Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.1.1. Multiple Sclerosis

      17.1.2. Other CNS drugs

      17.1.3. Anti-Psychotic

      17.1.4. Anti-Epileptics

      17.1.5. Antidepressants

      17.1.6. Anesthetics

      17.1.7. Analgesics

      17.1.8. Anti-Parkinson drugs

      17.2. Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.2.1. Hospital Pharmacies

      17.2.2. Retail Pharmacies/ Drug Stores

      17.2.3. Other Distribution Channel

      17.3. Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.3.1. Oral

      17.3.2. Intravenous

      17.3.3. Intranasal

      17.3.4. Others

      17.4. Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.4.1. Branded Drugs

      17.4.2. Generic Drugs

      17.5. Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.5.1. Prescription-Based Drugs

      17.5.2. Over-The-Counter Drugs

      18. Global Central Nervous System Drugs Market Metrics

      18.1. Central Nervous System Drugs Market Size, Percentage Of GDP, Global

      18.2. Per Capita Average Central Nervous System Drugs Market Expenditure, Global

      19. Asia-Pacific Central Nervous System Drugs Market

      19.1. Asia-Pacific Central Nervous System Drugs Market Overview

      19.1.1. Region Information

      19.1.2. Market Information

      19.1.3. COVID-19 Impact

      19.1.4. Background Information

      19.1.5. Government Initiatives

      19.1.6. Regulations

      19.1.7. Regulatory Bodies

      19.1.8. Major Associations

      19.1.9. Taxes Levied

      19.1.10. Corporate Tax Structure

      19.1.11. Investments

      19.1.12. Major Companies

      19.2. Asia-Pacific Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.3. Asia-Pacific Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.4. Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19.5. Asia-Pacific Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

      19.6. Asia-Pacific Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country

      19.7. Asia-Pacific Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

      19.8. Asia-Pacific Central Nervous System Drugs Market Metrics

      19.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, Asia-Pacific Major Countries

      19.9. Asia-Pacific Central Nervous System Drugs Market: Country Analysis

      19.10. Australia Central Nervous System Drugs Market

      19.11. Australia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.12. Australia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.13. Australia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19.14. China Central Nervous System Drugs Market

      19.15. China Central Nervous System Drugs Market Overview

      19.15.1. Country Information

      19.15.2. Market Information

      19.15.3. COVID-19 Impact

      19.15.4. Background Information

      19.15.5. Government Initiatives

      19.15.6. Regulations

      19.15.7. Regulatory Bodies

      19.15.8. Major Associations

      19.15.9. Taxes Levied

      19.15.10. Corporate Tax Structure

      19.15.11. Investments

      19.15.12. Major Companies

      19.16. China Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.17. China Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.18. China Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19.19. Hong Kong Central Nervous System Drugs Market

      19.20. Hong Kong Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.21. Hong Kong Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.22. India Central Nervous System Drugs Market

      19.23. India Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.24. India Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.25. India Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19.26. Indonesia Central Nervous System Drugs Market

      19.27. Indonesia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.28. Indonesia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.29. Indonesia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19.30. Japan Central Nervous System Drugs Market

      19.31. Japan Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.32. Japan Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.33. Japan Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19.34. Malaysia Central Nervous System Drugs Market

      19.35. Malaysia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.36. Malaysia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.37. New Zealand Central Nervous System Drugs Market

      19.38. New Zealand Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.39. New Zealand Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.40. Philippines Central Nervous System Drugs Market

      19.41. Philippines Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.42. Philippines Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.43. Singapore Central Nervous System Drugs Market

      19.44. Singapore Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.45. Singapore Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.46. South Korea Central Nervous System Drugs Market

      19.47. South Korea Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.48. South Korea Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.49. South Korea Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19.50. Thailand Central Nervous System Drugs Market

      19.51. Thailand Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.52. Thailand Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.53. Vietnam Central Nervous System Drugs Market

      19.54. Vietnam Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.55. Vietnam Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      20. Western Europe Central Nervous System Drugs Market

      20.1. Western Europe Central Nervous System Drugs Market Overview

      20.1.1. Region Information

      20.1.2. Market Information

      20.1.3. COVID Impact

      20.1.4. Background Information

      20.1.5. Government Initiatives

      20.1.6. Regulations

      20.1.7. Regulatory Bodies

      20.1.8. Major Associations

      20.1.9. Taxes Levied

      20.1.10. Corporate Tax Structure

      20.1.11. Investments

      20.1.12. Major Companies

      20.2. Western Europe Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.3. Western Europe Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      20.4. Western Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      20.5. Western Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

      20.6. Western Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country

      20.7. Western Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

      20.8. Western Europe Central Nervous System Drugs Market Metrics

      20.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, Western Europe Major Countries

      20.9. Western Europe Central Nervous System Drugs Market: Country Analysis

      20.10. Austria Central Nervous System Drugs Market

      20.11. Austria Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.12. Austria Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      20.13. Belgium Central Nervous System Drugs Market

      20.14. Belgium Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.15. Belgium Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      20.16. Denmark Central Nervous System Drugs Market

      20.17. Denmark Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.18. Denmark Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      20.19. Finland Central Nervous System Drugs Market

      20.20. Finland Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.21. Finland Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      20.22. France Central Nervous System Drugs Market

      20.23. France Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.24. France Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      20.25. France Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      20.26. Germany Central Nervous System Drugs Market

      20.27. Germany Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.28. Germany Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      20.29. Germany Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      20.30. Ireland Central Nervous System Drugs Market

      20.31. Ireland Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.32. Ireland Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      20.33. Italy Central Nervous System Drugs Market

      20.34. Italy Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.35. Italy Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      20.36. Netherlands Central Nervous System Drugs Market

      20.37. Netherlands Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.38. Netherlands Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      20.39. Norway Central Nervous System Drugs Market

      20.40. Norway Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.41. Norway Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      20.42. Portugal Central Nervous System Drugs Market

      20.43. Portugal Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.44. Portugal Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      20.45. Spain Central Nervous System Drugs Market

      20.46. Spain Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.47. Spain Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      20.48. Sweden Central Nervous System Drugs Market

      20.49. Sweden Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.50. Sweden Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      20.51. Switzerland Central Nervous System Drugs Market

      20.52. Switzerland Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.53. Switzerland Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      20.54. UK Central Nervous System Drugs Market

      20.55. UK Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      20.56. UK Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      20.57. UK Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      21. Eastern Europe Central Nervous System Drugs Market

      21.1. Eastern Europe Central Nervous System Drugs Market Overview

      21.1.1. Region Information

      21.1.2. Market Information

      21.1.3. COVID Impact

      21.1.4. Background Information

      21.1.5. Government Initiatives

      21.1.6. Regulations

      21.1.7. Regulatory Bodies

      21.1.8. Major Associations

      21.1.9. Taxes Levied

      21.1.10. Corporate Tax Structure

      21.1.11. Investments

      21.1.12. Major Companies

      21.2. Eastern Europe Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      21.3. Eastern Europe Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      21.4. Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      21.5. Eastern Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

      21.6. Eastern Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country

      21.7. Eastern Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

      21.8. Eastern Europe Central Nervous System Drugs Market Metrics

      21.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, Eastern Europe Major Countries

      21.9. Eastern Europe Central Nervous System Drugs Market: Country Analysis

      21.10. Czech Republic Central Nervous System Drugs Market

      21.11. Czech Republic Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      21.12. Czech Republic Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      21.13. Poland Central Nervous System Drugs Market

      21.14. Poland Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      21.15. Poland Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      21.16. Romania Central Nervous System Drugs Market

      21.17. Romania Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      21.18. Romania Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      21.19. Russia Central Nervous System Drugs Market

      21.20. Russia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      21.21. Russia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      21.22. Russia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      22. North America Central Nervous System Drugs Market

      22.1. North America Central Nervous System Drugs Market Overview

      22.1.1. Region Information

      22.1.2. Market Information

      22.1.3. COVID-19 Impact

      22.1.4. Background Information

      22.1.5. Government Initiatives

      22.1.6. Regulations

      22.1.7. Regulatory Bodies

      22.1.8. Investments

      22.1.9. Major Associations

      22.1.10. Tax Levied

      22.1.11. Corporate Tax Structure

      22.1.12. Major Companies

      22.2. North America Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      22.3. North America Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      22.4. North America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      22.5. North America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

      22.6. North America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country

      22.7. North America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

      22.8. North America Central Nervous System Drugs Market Metrics

      22.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, North America Major Countries

      22.9. North America Central Nervous System Drugs Market: Country Analysis

      22.10. Canada Central Nervous System Drugs Market

      22.11. Canada Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      22.12. Canada Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      22.13. Mexico Central Nervous System Drugs Market

      22.14. Mexico Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      22.15. Mexico Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      22.16. USA Central Nervous System Drugs Market

      22.17. USA Central Nervous System Drugs Market Overview

      22.17.1. Country Information

      22.17.2. Market Information

      22.17.3. COVID-19 Impact

      22.17.4. Background Information

      22.17.5. Government Initiatives

      22.17.6. Regulations

      22.17.7. Regulatory Bodies

      22.17.8. Investments

      22.17.9. Major Associations

      22.17.10. Corporate Tax Structure

      22.17.11. Major Companies

      22.18. USA Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      22.19. USA Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      22.20. USA Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      23. South America Central Nervous System Drugs Market

      23.1. South America Central Nervous System Drugs Market Overview

      23.1.1. Region Information

      23.1.2. Market Information

      23.1.3. COVID-19 Impact

      23.1.4. Background Information

      23.1.5. Regulations

      23.1.6. Regulatory Bodies

      23.1.7. Investments

      23.1.8. Major Associations

      23.1.9. Tax Levied

      23.1.10. Corporate Tax Structure

      23.1.11. Major Companies

      23.2. South America Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      23.3. South America Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      23.4. South America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      23.5. South America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

      23.6. South America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country

      23.7. South America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

      23.8. South America Central Nervous System Drugs Market Metrics

      23.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, South America Major Countries

      23.9. South America Central Nervous System Drugs Market: Country Analysis

      23.10. Argentina Central Nervous System Drugs Market

      23.11. Argentina Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      23.12. Argentina Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      23.13. Brazil Central Nervous System Drugs Market

      23.14. Brazil Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      23.15. Brazil Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      23.16. Brazil Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      23.17. Chile Central Nervous System Drugs Market

      23.18. Chile Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      23.19. Chile Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      23.20. Colombia Central Nervous System Drugs Market

      23.21. Colombia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      23.22. Colombia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      23.23. Peru Central Nervous System Drugs Market

      23.24. Peru Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      23.25. Peru Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      23.26. Venezuela Central Nervous System Drugs Market

      23.27. Venezuela Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      23.28. Venezuela Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      24. Middle East Central Nervous System Drugs Market

      24.1. Middle East Central Nervous System Drugs Market Overview

      24.1.1. Region Information

      24.1.2. Market Information

      24.1.3. COVID-19 Impact

      24.1.4. Background Information

      24.1.5. Government Initiatives

      24.1.6. Regulations

      24.1.7. Regulatory Bodies

      24.1.8. Major Associations

      24.1.9. Taxes Levied

      24.1.10. Corporate Tax Structure

      24.1.11. Investments

      24.1.12. Major Companies

      24.2. Middle East Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      24.3. Middle East Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      24.4. Middle East Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      24.5. Middle East Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

      24.6. Middle East Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country

      24.7. Middle East Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

      24.8. Middle East Central Nervous System Drugs Market Metrics

      24.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, Middle East Major Countries

      24.9. Middle East Central Nervous System Drugs Market: Country Analysis

      24.10. Israel Central Nervous System Drugs Market

      24.11. Israel Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      24.12. Israel Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      24.13. Saudi Arabia Central Nervous System Drugs Market

      24.14. Saudi Arabia Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      24.15. Saudi Arabia Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      24.16. Turkey Central Nervous System Drugs Market

      24.17. Turkey Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      24.18. Turkey Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      24.19. UAE Central Nervous System Drugs Market

      24.20. UAE Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      24.21. UAE Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      25. Africa Central Nervous System Drugs Market

      25.1. Africa Central Nervous System Drugs Market Overview

      25.1.1. Region Information

      25.1.2. Market Information

      25.1.3. COVID-19 Impact

      25.1.4. Background Information

      25.1.5. Government Initiatives

      25.1.6. Regulations

      25.1.7. Regulatory Bodies

      25.1.8. Major Associations

      25.1.9. Taxes Levied

      25.1.10. Corporate Tax Structure

      25.1.11. Investments

      25.1.12. Major Companies

      25.2. Africa Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      25.3. Africa Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      25.4. Africa Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      25.5. Africa Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)

      25.6. Africa Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast, By Country

      25.7. Africa Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country

      25.8. Africa Central Nervous System Drugs Market Metrics

      25.8.1. Per Capita Central Nervous System Drugs Expenditure, 2020, Africa Major Countries

      25.9. Africa Central Nervous System Drugs Market: Country Analysis

      25.10. Egypt Central Nervous System Drugs Market

      25.11. Egypt Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      25.12. Egypt Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      25.13. Nigeria Central Nervous System Drugs Market

      25.14. Nigeria Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      25.15. Nigeria Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      25.16. South Africa Central Nervous System Drugs Market

      25.17. South Africa Central Nervous System Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      25.18. South Africa Central Nervous System Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      26. Global Central Nervous System Drugs Market Competitive Landscape

      26.1. Biogen Inc.

      26.1.1. Company Overview

      26.1.2. Products And Services

      26.1.3. Business Strategy

      26.1.4. Financial Overview

      26.2. Johnson & Johnson

      26.2.1. Company Overview

      26.2.2. Products And Services

      26.2.3. Business Strategy

      26.2.4. Financial Overview

      26.3. Hoffmann-La Roche Ltd

      26.3.1. Company Overview

      26.3.2. Products And Services

      26.3.3. Business Strategy

      26.3.4. Financial Overview

      26.4. Novartis AG

      26.4.1. Company Overview

      26.4.2. Products And Services

      26.4.3. Business Strategy

      26.4.4. Financial Overview

      26.5. UCB

      26.5.1. Company Overview

      26.5.2. Products And Services

      26.5.3. Business Strategy

      26.5.4. Financial Overview

      27. Key Mergers And Acquisitions In The Central Nervous System Drugs Market

      27.1. Ethypharm Acquired Altan Pharma

      27.2. Angelini Pharma Acquired Arvelle Therapeutics

      27.3. Novartis Acquired Cadent Therapeutics

      27.4. Biogen Acquired Sangamo Therapeutics

      27.5. Supernus Acquired US WorldMeds

      27.6. Permira Acquired Neuraxpharm

      27.7. UCB Acquired Handl Therapeutics

      27.8. Neurocrine Biosciences Acquired Voyager Therapeutics

      27.9. Eli Lilly Acquired Loxo Oncology Inc.

      27.10. Neuraxpharm Acquired Farmax

      27.11. CNS Pharmaceuticals Acquired Houston Pharmaceuticals Inc.

      27.12. H. Lundbeck Acquired Prexton Therapeutics

      27.13. Novartis Acquired AveXis

      27.14. Biolab Pharma Acquired Avtavis Brazil

      27.15. Mitsubishi Tanabe Pharma Acquired NeuroDerm

      27.16. Eli Lilly Acquires CoLucid

      27.17. Lupin Acquired Temmler Pharma

      28. Market Background: Pharmaceutical Drugs Market

      28.1. Pharmaceutical Drugs Market Characteristics

      28.1.1. Market Definition

      28.1.2. Segmentation By Type

      28.2. Global Pharmaceutical Drugs Market, Segmentation By Type, 2015 – 2025, Value ($ Billion)

      28.3. Global Pharmaceutical Drugs Market, 2020, By Region, Value ($ Billion)

      28.4. Global Pharmaceutical Drugs Market, 2015 – 2025, Historic And Forecast, By Region

      29. Central Nervous System Drugs Market Future Outlook and Potential Analysis

      29.1. Global Central Nervous System Drugs Market In 2025 – Countries Offering Most New Opportunities

      29.2. Global Central Nervous System Drugs Market In 2025 – Segments Offering Most New Opportunities

      29.3. Global Central Nervous System Drugs Market In 2025 – Growth Strategies

      29.3.1. Market Trend Based Strategies

      29.3.2. Competitor Strategies

      30. Appendix

      30.1. Market Data Sources

      30.2. NAICS Definitions Of Industry Covered In This Report

      30.3. Research Methodology

      30.4. Currencies

      30.5. Research Inquiries

      30.6. The Business Research Company

      30.7. Copyright and Disclaimer

    List Of Tables

      Table 1 : Global Central Nervous System Drugs Market, Product Analysis – Product Examples
    • Table 2: Global Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 3: Global Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 4: Global Central Nervous System Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 5: Global Central Nervous System Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 6: Global Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
    • Table 7: Global Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Region
    • Table 8: Global Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 9: Global Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 10: Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 11: Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 12: Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 13: Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 14: Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 15: Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 16: Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 17: Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 18: Global Central Nervous System Drugs Market Value, Market Size As A Percentage Of Global GDP, 2015 – 2025
    • Table 19: Global Central Nervous System Drugs Market, Per Capita Average Central Nervous System Drugs Market Industry Expenditure, 2015 – 2025, ($)
    • Table 20:  Asia-Pacific Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 21:  Asia-Pacific Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 22: Asia-Pacific Per Capita Net Disposable Income, 2015-2019, $
    • Table 23:  Asia Pacific Population By Age Group, 2015-2023, Thousands
    • Table 24: Asia-Pacific Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 25: Asia-Pacific Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 26: Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 27: Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 28: Asia-Pacific Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
    • Table 29: Asia-Pacific Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 30: Asia-Pacific Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 31: Asia-Pacific Per Capita Central Nervous System Drugs Expenditure, By Country, 2020, $
    • Table 32: Australia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 33: Australia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 34: Australia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 35: Australia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 36:  China Pharmaceuticals, 2015-2020, $ Billion
    • Table 37:  China Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 38:  China Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 39: China Per Capita Net Disposable Income, 2015-2019, $
    • Table 40:  China Population By Age Group, 2015-2023, Thousands
    • Table 41: China Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 42: China Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 43: China Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 44: China Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 45: Hong Kong Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 46: Hong Kong Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 47: India Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 48: India Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 49: India Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 50: India Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 51: Indonesia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 52: Indonesia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 53: Indonesia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 54: Indonesia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 55: Japan Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 56: Japan Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 57: Japan Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 58: Japan Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 59: Malaysia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 60: Malaysia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 61: New Zealand Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 62: New Zealand Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 63: Philippines Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 64: Philippines Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 65: Singapore Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 66: Singapore Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 67: South Korea Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 68: South Korea Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 69: South Korea Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 70: South Korea Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 71: Thailand Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 72: Thailand Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 73: Vietnam Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 74: Vietnam Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 75: Western Europe Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 76: Western Europe Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 77: Western Europe Per Capita Net Disposable Income, 2015-2019, $
    • Table 78:  Western Europe Population By Age Group, 2015-2023, Thousands
    • Table 79: Western Europe Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 80: Western Europe Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 81: Western Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 82: Western Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 83: Western Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
    • Table 84: Western Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 85: Western Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 86: Western Europe Per Capita Central Nervous System Drugs Expenditure, By Country, 2020, $
    • Table 87: Austria Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 88: Austria Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 89: Belgium Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 90: Belgium Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 91: Denmark Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 92: Denmark Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 93: Finland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 94: Finland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 95: France Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 96: France Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 97: France Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 98: France Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 99: Germany Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 100: Germany Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 101: Germany Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 102: Germany Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 103: Ireland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 104: Ireland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 105: Italy Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 106: Italy Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 107: Netherlands Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 108: Netherlands Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 109: Norway Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 110: Norway Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 111: Portugal Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 112: Portugal Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 113: Spain Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 114: Spain Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 115: Sweden Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 116: Sweden Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 117: Switzerland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 118: Switzerland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 119: UK Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 120: UK Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 121: UK Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 122: UK Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 123: Eastern Europe Public Healthcare Expenditure, 2015-2019,$Billion
    • Table 124: Eastern Europe Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 125: Eastern Europe Per Capita Net Disposable Income, 2015-2019, $
    • Table 126:  Eastern Europe Population By Age Group, 2015-2023, Thousands
    • Table 127: Eastern Europe Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 128: Eastern Europe Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 129: Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 130: Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 131: Eastern Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
    • Table 132: Eastern Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 133: Eastern Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 134: Eastern Europe Per Capita Central Nervous System Drugs Expenditure, By Country, 2020, $
    • Table 135: Czech Republic Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 136: Czech Republic Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 137: Poland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 138: Poland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 139: Romania Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 140: Romania Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 141: Russia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 142: Russia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 143: Russia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 144: Russia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 145:  North America Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 146:  North America Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 147: North America Per Capita Net Disposable Income, 2015-2019, $
    • Table 148:  North America Population By Age Group, 2015-2023, Thousands
    • Table 149: North America Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 150: North America Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 151: North America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 152: North America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 153: North America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
    • Table 154: North America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 155: North America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 156: North America Per Capita Central Nervous System Drugs Expenditure, By Country, 2020, $
    • Table 157: Canada Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 158: Canada Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 159: Mexico Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 160: Mexico Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 161:  USA Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 162:  USA Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 163: USA Per Capita Net Disposable Income, 2015-2019, $
    • Table 164:  USA Market, Population By Age Group, 2015-2023, Thousands
    • Table 165: USA Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 166: USA Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 167: USA Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 168: USA Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 169: South America Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 170: South America Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 171: South America Per Capita Net Disposable Income, 2015-2019, $
    • Table 172:  South America Population By Age Group, 2015-2023, Thousands
    • Table 173: South America Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 174: South America Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 175: South America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 176: South America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 177: South America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
    • Table 178: South America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Table 179: South America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Table 180: South America Per Capita Central Nervous System Drugs Expenditure, By Country, 2020, $

    List Of Figures

      Figure 1: Global Central Nervous System Drugs Market Segmentation By Type
    • Figure 2: Global Central Nervous System Drugs Market Segmentation By Distribution Channel
    • Figure 3: Global Central Nervous System Drugs Market Segmentation By Route Of Administration
    • Figure 4: Global Central Nervous System Drugs Market Segmentation By Drug Classification
    • Figure 5: Global Central Nervous System Drugs Market Segmentation By Mode Of Purchase
    • Figure 6: Market Supply Chain For Central Nervous System Drugs
    • Figure 7: Global Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 8: Global Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 9: Global Central Nervous System Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 10: Global Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
    • Figure 11: Global Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Region
    • Figure 12: Global Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 13: Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 14: Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 15: Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 16: Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 17: Asia-Pacific Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 18: Asia-Pacific Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 19: Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 20: Asia-Pacific Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
    • Figure 21: Asia-Pacific Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 22: Asia-Pacific Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 23: Australia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 24: Australia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 25: Australia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 26: China Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 27: China Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 28: China Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 29: Hong Kong Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 30: Hong Kong Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 31: India Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 32: India Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 33: India Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 34: Indonesia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 35: Indonesia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 36: Indonesia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 37: Japan Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 38: Japan Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 39: Japan Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 40: Malaysia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 41: Malaysia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 42: New Zealand Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 43: New Zealand Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 44: Philippines Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 45: Philippines Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 46: Singapore Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 47: Singapore Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 48: South Korea Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 49: South Korea Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 50: South Korea Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 51: Thailand Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 52: Thailand Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 53: Vietnam Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 54: Vietnam Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 55: Western Europe Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 56: Western Europe Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 57: Western Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 58: Western Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
    • Figure 59: Western Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 60: Western Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 61: Austria Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 62: Austria Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 63: Belgium Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 64: Belgium Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 65: Denmark Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 66: Denmark Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 67: Finland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 68: Finland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 69: France Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 70: France Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 71: France Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 72: Germany Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 73: Germany Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 74: Germany Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 75: Ireland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 76: Ireland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 77: Italy Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 78: Italy Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 79: Netherlands Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 80: Netherlands Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 81: Norway Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 82: Norway Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 83: Portugal Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 84: Portugal Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 85: Spain Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 86: Spain Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 87: Sweden Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 88: Sweden Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 89: Switzerland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 90: Switzerland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 91: UK Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 92: UK Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 93: UK Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 94: Eastern Europe Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 95: Eastern Europe Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 96: Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 97: Eastern Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
    • Figure 98: Eastern Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 99: Eastern Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 100: Czech Republic Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 101: Czech Republic Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 102: Poland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 103: Poland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 104: Romania Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 105: Romania Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 106: Russia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 107: Russia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 108: Russia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 109: North America Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 110: North America Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 111: North America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 112: North America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
    • Figure 113: North America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 114: North America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 115: Canada Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 116: Canada Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 117: Mexico Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 118: Mexico Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 119: USA Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 120: USA Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 121: USA Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 122: South America Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 123: South America Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 124: South America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 125: South America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
    • Figure 126: South America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
    • Figure 127: South America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
    • Figure 128: Argentina Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 129: Argentina Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 130: Brazil Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 131: Brazil Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 132: Brazil Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 133: Chile Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 134: Chile Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 135: Colombia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 136: Colombia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 137: Peru Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 138: Peru Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 139: Venezuela Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 140: Venezuela Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 141: Middle East Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
    Global Anti-Infective Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Cell and Gene Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Pharmaceutical Drugs And Biologics Logistics Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Pharmaceutical Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Microbiome Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global G-CSF (Granulocyte Colony Stimulating Factors) Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Therapeutic Proteins Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Ophthalmology Drugs Market - By Type (Antiglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Prescription Type (OTC Drugs, Prescription Drugs), By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Drug Variation (Branded Drugs, Generic Drugs), And, By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Drugs For Benign Prostatic Hypertrophy Global Market Report 2021 - By Type (Alpha Blocker, 5-alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitor), By End User (Hospital Pharmacies, Retail Pharmacies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), COVID-19 Impact And Recovery
    View Report
    Drugs For Hormonal Replacement Therapy Global Market Report 2021 - By Therapy Type (Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, Menopause), By Route of Administration (Oral, Parental), COVID-19 Impact and Recovery
    View Report
    Drugs For Immunotherapy Global Market Report 2021 - By Type (Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors), By Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases), By End User: Hospitals & Clinics, Ambulatory Surgical Centers), COVID-19 Growth And Change
    View Report
    Anti-Parkinson Drugs Global Market Report 2021 - By Drugs Class (Levodopa/Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-inhibitors, Anticholinergics, Other Drugs). By Route of Administration (Oral, Injection, Transdermal). By Distribution Channel (Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies), COVID-19 Impact and Recovery
    View Report
    Analgesics Global Market Report 2021 - By Type (Non-opioids, Opioids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores), By Route of Administration (Oral, Intravenous, Rectal, Transdermal, Topical), By Drug Type (Prescription Analgesics, OTC Analgesics), By Application (Internal Analgesics, External Analgesics), COVID-19 Implications And Growth
    View Report
    Anesthetics Global Market Report 2021 - By Type (General Anesthetics, Local Anesthetics), By Application (General Surgeries, Plastic Surgery, Cosmetic Surgeries, Dental Surgeries), By Route of Administration (Inhalation Anaesthesia Drugs, Intravenous Anaesthesia Drugs, Topical Anaesthesia Drugs), By Local Anesthetics (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Articaine, Benzocaine), By General Anesthetics (Propofol, Sevoflurane, Desflurane, Dexmedetomidine, Remifentanil, Midazolam), COVID-19 Implications And Growth
    View Report
    Musculoskeletal Disorders Drugs Global Market Report 2021 - By Type (Anti Diabetics drugs, Anti-Thyroid Drugs, Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), COVID-19 Impact And Recovery
    View Report

    Call Us

    +1 3156230293

    (Americas)

    +44 2071930708

    (Europe)

    +91 8897263534

    (Asia & Others)